Why the study?
Does genetic ablation of Bmi1+ progenitor cells impair angiogenesis and ejection fraction in a mouse model of myocardial infarction?
Does genetic ablation of Bmi1+ progenitor cells impair angiogenesis and ejection fraction in a mouse model of myocardial infarction?
Bmi1+ progenitor cells are essential for injury-induced neovascularization and preservation of ejection fraction after myocardial infarction in mice.
Bmi1+ progenitors support post-MI neovascularization and EF in mice; leaves open human therapeutic targeting.
Objective— Cardiac progenitor cells reside in the heart in adulthood, although their physiological relevance remains unknown. Here, we demonstrate that after myocardial infarction, adult Bmi1+(B lymphoma Mo-MLV insertion region 1 homolog [PCGF4]) cardiac cells are a key progenitor-like population in cardiac neovascularization during ventricular remodeling. Approach and Results— These cells, which have a strong in vivo differentiation bias, are a mixture of endothelial- and mesenchymal-related cells with in vitro spontaneous endothelial cell differentiation capacity. Genetic lineage tracing analysis showed that heart-resident Bmi1+progenitor cells proliferate after acute myocardial infarction and differentiate to generate de novo cardiac vasculature. In a mouse model of induced myocardial infarction, genetic ablation of these cells substantially deteriorated both heart angiogenesis and the ejection fraction, resulting in an ischemic-dilated cardiac phenotype. Conclusions— These findings imply that endothelial-related Bmi1+progenitor cells are necessary for injury-induced neovascularization in adult mouse heart and highlight these cells as a suitable therapeutic target for preventing dysfunctional left ventricular remodeling after injury.
No takes yet. Share an insight, caveat, or question.
Herrero et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: